Bias in artificial intelligence impacts drug development : AiCure
In our series of letters from African journalists, scientists and academics explain how bias in artificial intelligence and other advanced data analysis can affect the results of clinical trials in the UK and the world. Here are some of the key questions being discussed.
Source: outsourcing-pharma.comPublished on 2021-12-20
Related news
- Data revolution in Indian agriculture
- Nvidia accused of cheating in big - data performance test by benchmark umpires : Workloads tweaked to beat rivals in TPCx - BB
- Equity Through Data and Privacy Program Launches in San Jose
- Unique Network Chosen As Exclusive Blockchain Partner for United Nations Associated NFT Climate ...
- Visa announces new country manager for Singapore , Brunei
- Collective action on extractive sector corruption to take place
- Business Lending Partnership Gives Westpac Customers Faster Access To Funds
- Shift to e - learning is on the rise
- The Data Decade : reflecting back and looking forward
- Education Secretary leads call to tackle antisemitic abuse on campuses
- Convex launches Seascape Survey Partnership with Blue Marine Foundation
- Nordic insurtech raised 19M to digitize the insurance market
- Chihuahuas most targeted breed of dog by pet thieves in Northamptonshire , police data shows
- SGX Nifty indicates muted start for domestic markets - The Hindu BusinessLine
- Collective action on extractive sector corruption can turn the tide